Stock comparison
Mettler-Toledo International
Teva Pharmaceutical Industries Limited
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
TEVA
Teva Pharmaceutical Industries Limited
Market cap
$39.67B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | TEVA | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 46D | MTD |
| Benjamin Graham | 65B | 60D | MTD |
| Philip Fisher | 63C | 59C | MTD |
| Peter Lynch | 66B | 53C | MTD |
| Joel Greenblatt | 68B | 49D | MTD |
| Charlie Munger | 74B | 50D | MTD |
| Terry Smith | 70B | 41D | MTD |
Side-by-side metrics
| Metric | MTD | TEVA |
|---|---|---|
| Market cap | $22.29B | $39.67B |
| P/E (TTM) | 25.3x | 25.4x |
| EV/EBIT | 21.6x | 24.8x |
| ROIC (TTM) | 36.09% | 11.49% |
| Gross margin | 57.79% | 51.98% |
| Net margin | 21.4% | 9.03% |
| Revenue CAGR 5y | 2.01% | 2.1% |
| EPS CAGR 5y | 6.12% | 34.13% |
| Debt / Equity | - | 2.1x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 2.1x+104%
- ROIC (TTM)36.09%vs 11.49%+68%
- Net margin21.4%vs 9.03%+58%
- EV/EBIT21.6xvs 24.8x+13%
TEVA leads on
- EPS CAGR 5y34.13%vs 6.12%+82%
- Market cap$39.67Bvs $22.29B+44%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.